NICOX (EPA:COX) | Finanzwire

Basculer en Français

10401	Companies
217373	Keywords
147002	Articles
115069	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 06/06/2025 at 07:30, 11 months 7 days ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation
BRIEF

published on 05/27/2025 at 07:35, 11 months 17 days ago

Nicox secures up to €3 million from Kowa to advance NCX 470

Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
BRIEF

published on 05/14/2025 at 07:35, 11 months 30 days ago

Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial

Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
PRESS RELEASE

published on 05/14/2025 at 07:30, 11 months 30 days ago

Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial

Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF

published on 04/30/2025 at 07:35, 1 year ago

Nicox Reports Full Year 2024 Financials

Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
PRESS RELEASE

published on 04/30/2025 at 07:30, 1 year ago

Nicox Provides Full Year 2024 Financial Results
Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025

Financial Results Revenue Nicox NCX 470 VYZULTA
BRIEF

published on 03/19/2025 at 07:35, 1 year 1 month ago

Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial

Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE

published on 03/19/2025 at 07:30, 1 year 1 month ago

Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025

Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF

published on 01/28/2025 at 07:35, 1 year 3 months ago

Nicox: Participation in Major Congresses in 2025

Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE

published on 01/28/2025 at 07:30, 1 year 3 months ago

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025

Conference Ophthalmology Nicox NCX 470 AGS 2025

Accesswire

Published on 05/14/2026 at 00:00, 1 hour 52 minutes ago

BEACN Announces Creation of Loan Program
Published on 05/13/2026 at 23:30, 2 hours 22 minutes ago

CCL Industries Announces Results for 2026 First Quarter
Published on 05/13/2026 at 23:15, 2 hours 37 minutes ago

Avino Delivers Record Q1 2026 Financial Results
Published on 05/13/2026 at 23:05, 2 hours 47 minutes ago

Vox Royalty Reports Record Q1 2026 Results, Increases 2026 Guidance and Declares Quarterly Dividend
Published on 05/13/2026 at 22:30, 3 hours 22 minutes ago

Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure

View all ACCESSWIRE

EQS Group

Published on 05/14/2026 at 01:05, 46 minutes ago

THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 3 hours 31 minutes ago

Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:21, 5 hours 31 minutes ago

Northern Data provides operational update
Published on 05/13/2026 at 20:18, 5 hours 33 minutes ago

EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 6 hours 23 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/13/2026 at 18:00, 7 hours 52 minutes ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 17:45, 8 hours 7 minutes ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 8 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 8 hours 12 minutes ago

Report on share repurchases from 6 to 12 May 2026
Published on 05/13/2026 at 16:00, 9 hours 52 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE